BPC-157 / TB-500 Blend for Dogs โ Canine Joint Repair Research Guide
Research-based canine dosing, cycling, safety, and breed cautions for BPC-157 / TB-500 Blend in dogs. Separate from the human database โ dog dosing is different from human dosing.
Category
๐ฆด Joint Repair
Route
Subcutaneous
Frequency
Once daily (BPC component) + 2x weekly (TB-500 component)
Cycle length
4 weeks
Break
4 weeks off
Per-dose range
50 mcg โ 750 mcg
Evidence level: Preclinical (animal data). No human clinical trials โ based on preclinical/animal data. Canine-specific studies are limited; dog dosing here is a conservative extrapolation for research reference.
What is BPC-157 / TB-500 Blend for dogs?
BPC-157 / TB-500 Blend is a research peptide used in canine contexts for joint repair. In dogs it works through the same core mechanism as in humans: combination vial pairing BPC-157 (angiogenesis, collagen synthesis, gut lining repair) with TB-500 (cell migration, tissue remodeling, inflammation reduction) โ the two most-studied healing peptides in one synergistic research schedule for tendon, ligament, and joint injuries in dogs.
Veterinary interest in BPC-157 / TB-500 Blend for dogs comes from its joint repair effects, and this guide is built for the canine use case specifically. The blend mirrors the classic veterinary injury-repair pairing: daily BPC-157 for blood-vessel and collagen support with twice-weekly TB-500 for tissue remodeling โ in one vial. Dosing follows the BPC component (~5-10 mcg/kg daily); the TB-500 component is delivered on top twice weekly. Evidence is preclinical for both components.
Evidence honesty: No human clinical trials โ based on preclinical/animal data. Canine-specific studies are limited; dog dosing in this guide is extrapolated conservatively from the available veterinary and laboratory data.
BPC-157 / TB-500 Blend dosing for dogs (research reference)
Canine research dosing is weight-based โ approximately 7.5 mcg per kg of body weight,once daily (bpc component) + 2x weekly (tb-500 component), by the subcutaneous route. That puts the per-administration range at roughly 50 mcg โ 750 mcg depending on the dog's size.
| Breed size | Example breeds | Example dose |
|---|---|---|
| Small (~5 kg) | Chihuahua, Yorkie, Shih Tzu | 50 mcg |
| Medium (~15 kg) | Beagle, Border Collie, Cocker Spaniel | 113 mcg |
| Large (~30 kg) | Labrador, German Shepherd, Golden Retriever | 225 mcg |
| Giant (~50 kg) | Great Dane, Mastiff, Saint Bernard | 375 mcg |
Dose calculation formula
dose (mcg) = 7.5 mcg/kg ร body weight (kg) ร size/senior factors
The guide builder applies a conservative factor for small and giant breeds and for senior dogs, and clamps doses to the 50 mcg โ 750 mcg research range. Never use human doses on dogs.
Veterinary & cycle notes
The blend mirrors the classic veterinary injury-repair pairing: daily BPC-157 for blood-vessel and collagen support with twice-weekly TB-500 for tissue remodeling โ in one vial. Dosing follows the BPC component (~5-10 mcg/kg daily); the TB-500 component is delivered on top twice weekly. Evidence is preclinical for both components.
Weight, age, breed size, and safety screening included
BPC-157 / TB-500 Blend cycle & break: 4 weeks, then 4 weeks off
Research cycle
4 weeks
Break
4 weeks off
Cycling matters for dogs the same way it does in research settings: the break gives the body a reset window and mirrors how course-based peptides are used in veterinary practice. Do not run continuous open-ended cycles, and reassess with your veterinarian at the end of every cycle.
BPC-157 / TB-500 Blend side effects & safety in dogs
Watch-fors / expected effects
- Mild injection-site irritation
- Transient appetite change (rare)
- Lethargy after TB-500 doses (rare)
Dogs can't tell you how they feel โ track appetite, energy, stool quality, and behavior daily.
Not appropriate for
- Pregnant
- Nursing
- Puppies under 1 year
- Cancer
- Active tumor
- Autoimmune
- Upcoming surgery โ hold 1-2 weeks before
- Nsaid or anticoagulant use (bleeding risk)
๐พ Collie / Shetland / Shepherd / Sheepdog / Australian: Herding breeds can carry the MDR1 (ABCB1) gene mutation, which makes them unusually sensitive to many drugs. Confirm MDR1 status with your veterinarian before starting anything new.
Research use only โ read before starting
BPC-157 / TB-500 Blend is not FDA-approved for use in dogs. Nothing on this page is veterinary advice โ it is a research reference for conversations with your veterinarian. Call your vet if your dog has vomiting or diarrhea lasting over 24 hours, refuses food for more than one meal, shows unusual lethargy, pale gums, spreading injection-site swelling, seizures, or any sudden behavior change. Stop first, then call.
BPC-157 / TB-500 Blend for dogs โ FAQ
Is BPC-157 / TB-500 Blend safe for dogs?
BPC-157 / TB-500 Blend is not FDA-approved for use in dogs. Research (largely preclinical animal) studies and veterinary case use suggest it is generally well tolerated at conservative doses, but dog-specific safety data is limited. Known side effects in dogs are usually mild (mild injection-site irritation, transient appetite change (rare)). Always get your dog cleared by a veterinarian first โ especially with conditions like pregnancy, cancer, or autoimmune disease.
How much BPC-157 / TB-500 Blend should I give my dog?
Canine research dosing for BPC-157 / TB-500 Blend is roughly 7.5 mcg per kg of body weight, once daily (bpc component) + 2x weekly (tb-500 component), by the subcutaneous route โ which works out to approximately 50 mcg โ 750 mcg per dose depending on the dog's size. Size examples: Small (~5 kg): 50 mcg ยท Medium (~15 kg): 113 mcg ยท Large (~30 kg): 225 mcg ยท Giant (~50 kg): 375 mcg. Small breeds dose at the low end; giant breeds stay conservative. This is a research reference, not a dosing instruction โ your veterinarian should confirm any amount.
Can I use my own BPC-157 / TB-500 Blend vial for my dog?
No โ never use human doses on dogs. Human peptide doses are far higher than canine doses for most compounds, and dog metabolism differs from ours in ways that matter. The vial may be the same compound, but the concentration, volume, and dose must be calculated for your dog's weight. If a veterinarian agrees to supervise BPC-157 / TB-500 Blend use, they should specify the exact dose and reconstitution for your dog.
How long should a dog stay on BPC-157 / TB-500 Blend?
Typical canine research cycles are 4 weeks, followed by 4 weeks off. Course-based bioregulators (BPC-157 / TB-500 Blend in some uses) deliberately run short courses with long breaks. Cycling gives the body a reset window and mirrors how these peptides are used in veterinary practice. Do not run continuous open-ended cycles.
What are the side effects of BPC-157 / TB-500 Blend in dogs?
Reported/expected effects in dogs are usually mild: Mild injection-site irritation, Transient appetite change (rare), Lethargy after TB-500 doses (rare). Because dogs cannot report how they feel, watch appetite, energy, stool quality, and behavior daily. Call your veterinarian if vomiting or diarrhea lasts over 24 hours, food is refused for more than one meal, or you see pale gums, spreading swelling, or any sudden behavior change.
Which dogs should NOT use BPC-157 / TB-500 Blend?
Contraindicated for: pregnant; nursing; puppies under 1 year; cancer; active tumor; autoimmune; upcoming surgery โ hold 1-2 weeks before; nsaid or anticoagulant use (bleeding risk). Breed-specific caution: collie/shetland/shepherd/sheepdog/australian-type breeds โ Herding breeds can carry the MDR1 (ABCB1) gene mutation, which makes them unusually sensitive to many drugs. Confirm MDR1 status with your veterinarian before starting anything new. When in doubt, ask your veterinarian before starting anything new.
Is there clinical research on BPC-157 / TB-500 Blend for dogs?
BPC-157 / TB-500 Blend evidence level: Preclinical (animal data). No human clinical trials โ based on preclinical/animal data (laboratory studies, some canine-specific). For joint repair in dogs specifically, most dosing is extrapolated from laboratory studies and limited veterinary use rather than controlled canine clinical trials.
Related dog research guides
BPC-157 for dogs
๐ฆด Joint RepairAccelerates angiogenesis (new blood vessel formation) and promotes collagen synthesis, tendon-to-bone healing, and gut lining repair by modulating growth factor expression
View research guide โ
TB-500 for dogs
๐ช Recovery & HealingSynthetic version of thymosin beta-4 that promotes cell migration, tissue remodeling, and reduced inflammation
View research guide โ
KPV for dogs
๐ช Recovery & HealingTripeptide (Lys-Pro-Val) derived from alpha-MSH that enters cells and directly inhibits NF-ฮบB-driven inflammation
View research guide โ
ARA-290 for dogs
๐ช Recovery & HealingErythropoietin-derived 11-amino-acid peptide that activates the innate repair receptor
View research guide โ
Disclaimer: For research and educational purposes only. Not veterinary advice. Consult your veterinarian. BPC-157 / TB-500 Blend is not FDA-approved for use in dogs, and canine evidence is largely preclinical โ doses and cycles here summarize published research, laboratory data, and limited veterinary case use. PeptideWise Pets does not sell peptides and has no financial relationship with any supplier or veterinary practice.
Build your dog's BPC-157 / TB-500 Blend research guide
Enter your dog's weight, age, breed size, and health profile โ the guide engine calculates the exact canine dose, builds the week-by-week calendar, and screens every recommendation against your dog's conditions and medications.
Start the guide builder